Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other financing activities (2018 - 2025)

Historic Other financing activities for CorMedix (CRMD) over the last 7 years, with Q3 2025 value amounting to $49192.0.

  • CorMedix's Other financing activities changed N/A to $49192.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year change of. This contributed to the annual value of $226855.0 for FY2019, which is 10853.14% up from last year.
  • As of Q3 2025, CorMedix's Other financing activities stood at $49192.0.
  • CorMedix's Other financing activities' 5-year high stood at $2.2 million during Q1 2023, with a 5-year trough of $49192.0 in Q3 2025.
  • In the last 3 years, CorMedix's Other financing activities had a median value of $1.1 million in 2022 and averaged $1.1 million.
  • The largest annual percentage gain for CorMedix's Other financing activities in the last 5 years was 9470.71% (2023), contrasted with its biggest fall of 152.33% (2023).
  • Quarter analysis of 3 years shows CorMedix's Other financing activities stood at $1.1 million in 2022, then dropped by 1.52% to $1.1 million in 2023, then plummeted by 95.35% to $49192.0 in 2025.
  • Its Other financing activities was $49192.0 in Q3 2025, compared to $1.1 million in Q2 2023 and $2.2 million in Q1 2023.